Yunnan Baiyao Group Investor Relations Material
Latest events
H1 2025
30 Aug, 2025
Q1 2025
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Yunnan Baiyao Group Co Ltd
Access all reports
Yunnan Baiyao Group Co., Ltd. specializes in the research, development, production, and sale of pharmaceutical and healthcare products. The company’s offerings include traditional Chinese medicine (TCM) products, over-the-counter (OTC) medications, personal care items, and health supplements. Its products are widely used in areas such as wound care, pain relief, and overall health maintenance. The company is headquartered in Kunming, China, and its shares are listed on the SZSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
000538
Country
🇨🇳 China